Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

Novo's strategy emphasises price cuts and accelerated launches, while Lilly's products benefitted from hitting the market ...

Atea Pharmaceuticals (AVIR) offers a late-stage, best-in-class HCV cure, with significant upside, currently trading below cash. BEM/RZR combines advantages of current first-line HCV therapies — single ...

Eli Lilly and Novo Nordisk are in a race to dominate India's booming obesity drug market. They are using aggressive marketing ...

I booked a business class seat for my American Airlines flight from St. Thomas to Charlotte, but 45 minutes before boarding, ...

Rian Johnson has created three compelling mysteries with his Knives Out movie trilogy, starring Daniel Craig, but which is ...

Here, we discuss three biotech stocks that put up a robust show in 2025 and are likely to maintain the same in 2026 on the back of a solid portfolio and a promising pipeline. These are EyePoint, Inc.

As we close the book on 2025, several interior designers share the living room trends they are asking begging you to leave in ...

In all its artistic iterations across millennia, the nativity remains inherently political in its depiction of God choosing ...

Injectable vitamins are being illicitly sold on the e-commerce platform Etsy, with one seller even surprising customers by ...

The "Motion Sickness Treatment Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering.